These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1425449)

  • 21. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
    Lin MF; Meng TC; Rao PS; Chang C; Schonthal AH; Lin FF
    J Biol Chem; 1998 Mar; 273(10):5939-47. PubMed ID: 9488733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    Jang YG; Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
    Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
    Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.
    Warriar N; Pagé N; Koutsilieris M; Govindan MV
    Prostate; 1994 Apr; 24(4):176-86. PubMed ID: 8146066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1999 Mar; 140(3):1205-12. PubMed ID: 10067845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways.
    Jones HE; Barrow D; Dutkowski CM; Goddard L; Smith C; Harper ME; Nicholson RI
    Prostate; 2001 Sep; 49(1):38-47. PubMed ID: 11550209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
    Guillemette C; Hum DW; Bélanger A
    Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells.
    Bhattacharyya RS; Krishnan AV; Swami S; Feldman D
    Mol Cancer Ther; 2006 Jun; 5(6):1539-49. PubMed ID: 16818513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
    Hobisch A; Fiechtl M; Sandahl-Sorensen B; Godoy-Tundidor S; Artner-Dworzak E; Ramoner R; Bartsch G; Culig Z
    Prostate; 2004 Jun; 59(4):401-8. PubMed ID: 15065088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.
    Ryan CJ; Zavodovskaya M; Youngren JF; Campbell M; Diamond M; Jones J; Shiry L; Allan G; Maddux BA; Goldfine ID
    Prostate; 2008 Aug; 68(11):1232-40. PubMed ID: 18491370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor.
    Izumi K; Zheng Y; Li Y; Zaengle J; Miyamoto H
    Int J Oncol; 2012 Nov; 41(5):1587-92. PubMed ID: 22922989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
    Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
    Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
    Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW
    Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
    Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
    Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells.
    Hackenberg R; Hawighorst T; Filmer A; Slater EP; Bock K; Beato M; Schulz KD
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):599-607. PubMed ID: 1472451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgens induce divergent proliferative responses in human breast cancer cell lines.
    Birrell SN; Bentel JM; Hickey TE; Ricciardelli C; Weger MA; Horsfall DJ; Tilley WD
    J Steroid Biochem Mol Biol; 1995 May; 52(5):459-67. PubMed ID: 7748811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
    Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
    Henttu P; Vihko P
    Cancer Res; 1993 Mar; 53(5):1051-8. PubMed ID: 7679946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.